NOK 21.1
Key Takeaways
Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company develops Webdoc, a cloud based EMR-system; and Vårdrummet, a digital platform for interactive health care that enables healthcare providers to communicate with their patients through digital services, such as video, chat, and other channels. It also provides...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.
Target Price
The average target price of CARA.OL is 25 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
